ESG at Organon: Achieving Her Promise

We are working to achieve a better and healthier every day for every woman through a focus on innovation, access, gender equity and environmental stewardship.

Download our 2025 ESG Executive Summary

Key 2025 achievements

transactions* completed since 2021, with four in 2025, which allows us to advance meaningfully toward our mission.

~87M

Helped prevent approximately 87 million unintended pregnancies** through the Her Promise Access Initiative, reaching nearly three quarters of the way towards our 2030 goal.

72M

Provided over 72 million women and girls in low- and middle-income countries (LMICs) with affordable access to contraceptive options.

95%

of our operational waste is reused, recycled or otherwise beneficially used.***

*“Transactions” include selected acquisitions, licenses, collaborations, divestitures and other strategic arrangements undertaken to advance our portfolio. Scope is defined by strategic relevance, may differ from SEC disclosures, and may not be directly comparable across periods.

**”Unintended pregnancies” are calculated based on the volumes supplied for the markets in scope and the impact is captured using the MSI Reproductive Choices Impact 2-v5 tool.

***”Otherwise beneficially used” includes composting and incinerated with heat recovery.

Creating a brighter future for her

“At Organon, we believe that how we operate is just as important as what we deliver. Our mission to deliver impactful medicines and solutions for a healthier every day guides how we create value – from advancing healthcare and investing in our people to conducting our business responsibly. The progress highlighted in this report reflects that commitment in action.”

—Joseph Morrissey, Organon CEO

Image of Carrie Cox Chairman Organon Board of Directors

“We remain committed to advancing our ESG priorities in support of our vision of a better and healthier every day for every woman. In 2025, we made meaningful progress toward our goal of helping prevent an estimated 120 million unintended pregnancies by 2030, reaching nearly three quarters of the way toward our 2030 goal. As we continue to address the health needs of women around the world, we are further embedding sustainability, equity, and responsible business practices into how we operate, innovate, and create lasting impact.”
– Carrie Cox, Executive Chairman, Organon’s Board of Directors and Robert Essner, Lead Independent Director and ESG Committee Chair

Image of Robert Essner, Chairman Organon Board ESG Committee

Her Promise, our purpose

We imagine a world where women, the backbone of a thriving and resilient society, can readily access solutions that meet their health needs — a world where a woman prospers, and so does her family, her community and her world for generations to come. By addressing health conditions unique to women, that affect them disproportionately or impact them differently, we are igniting our purpose to advance the complete health of women at all stages of their life journey.

We help women and girls achieve their promise through better health. By investing in high-need areas, including those that have no established precedent and where we believe the current standard of care is unacceptable, we are enabling needed innovation in women’s healthcare.

Our environmental, social and governance goals focus on three core areas: Her equity, Her planet and Her trust, along with the issues that matter most to our stakeholders, our business, and most importantly, women around the world.

illustration of woman with hair made of flowers

Our strategy and targets

We have completed our 2025 ESG goals that were established in 2021. In 2026, looking ahead to the next phase of our ESG journey and building on our strong foundation of completed goals, we launched a new five-year ESG plan. The 2030 goals focus on areas that matter most to our stakeholders, our business and, most importantly, women around the world. The plan and goals were reviewed and approved by Organon’s Board of Directors in April 2026.

Organon remains focused on advancing its ESG priorities and will continue to evaluate its strategy, goals, and reporting approach to reflect future business and organizational consideration.

Her equity

Throughout the world, women have vast unmet medical needs. Our goal is to redefine and harness innovation to help women and girls achieve their promise and lead healthier, more empowered lives.

The health of women depends on the health of our planet. While the ongoing climate crisis affects the entire world, pervasive gender inequality magnifies its impact on women and girls. Our goal is to implement environmentally friendly practices and long-term sustainability initiatives across our operations and value chain to positively impact women everywhere.

We aim to be a credible voice for women’s rights and gender equity. We are committed to upholding the highest levels of ethics and integrity throughout our business.